Bone healing: the diamond concept
What if you also enrolled 100 of those patients in CCM
For example, I currently use 0.25mg retatrutide (technically a triple-agonist that targets three pathways: glucagon, GLP-1, and gastric inhibitory polypeptide, injected three times a week, but since retatrutide is becoming harder to get, I will probably switch to tirzepatide soon ( Peptual is my peptide source )
And it found something the marketing never mentions: at the higher dose, 30 mL a day for 10 days, there was a signal of harm, with non-fatal serious adverse events nearly tripling, a risk ratio of 2.87 (1.24 to 6.69), across two trials and 1,189 people
This information should be interpreted with a qualified healthcare provider to support a more personalized understanding of your body's response